Insulet (NSDQ:PODD) announced that Elizabeth (Bess) Weatherman was appointed to its board of directors.
Weatherman — a veteran dealmaker in the health technology space — will stand for election by stockholders at the company’s 2022 annual meeting and has been named to the board’s Compensation Committee.
Get the full story at our sister site, Drug Delivery Business News.